Appointment of Dr Darren Patti to Group Chief Operating Officer
March 11, 2024 17:31 ET
|
Telix Pharmaceuticals Limited
MELBOURNE, Australia, March 12, 2024 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) is pleased to announce the appointment of Dr. Darren Patti as Group Chief...
Telix to Acquire ARTMS, Inc. and its Advanced Isotope Production Platform
March 04, 2024 17:42 ET
|
Telix Pharmaceuticals Limited
MELBOURNE, Australia, March 05, 2024 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces it has entered into an agreement to acquire radioisotope...
Telix Expands U.S. Development and Manufacturing Infrastructure with Acquisition of IsoTherapeutics
February 26, 2024 16:27 ET
|
Telix Pharmaceuticals Limited
MELBOURNE, Australia, Feb. 27, 2024 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces it has entered into an agreement to acquire IsoTherapeutics...
Telix 2023 Full Year Results: Inaugural Profit Achieved, Strong Revenue Growth Underpins Investment in Late-stage Pipeline
February 22, 2024 03:51 ET
|
Telix Pharmaceuticals Limited
MELBOURNE, Australia, Feb. 22, 2024 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces its results for the financial year ended 31 December 2023. All...
Telix Signs Agreement to Acquire QSAM Biosciences and Its Bone Cancer Targeting Platform
February 07, 2024 16:43 ET
|
Telix Pharmaceuticals Limited
MELBOURNE, Australia, Feb. 08, 2024 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces it has entered into an agreement to acquire QSAM Biosciences,...
Telix Highlights Presentations at Upcoming ASCO Genitourinary Cancers Symposium (ASCO GU 2024)
January 22, 2024 06:00 ET
|
Telix Pharmaceuticals Limited
MELBOURNE, Australia, Jan. 22, 2024 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces presentations featuring the Company’s theranostic programs at the...
Telix Announces Planned Registered Public Offering and Listing in the United States
January 04, 2024 16:59 ET
|
Telix Pharmaceuticals Limited
MELBOURNE, Australia, Jan. 05, 2024 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX:TLX, “Telix” or the “Company”) today announces that it is considering an initial public offering (“IPO”) of...
Telix to Present at the 42nd Annual J.P. Morgan Healthcare Conference
January 03, 2024 16:55 ET
|
Telix Pharmaceuticals Limited
MELBOURNE, Australia, Jan. 03, 2024 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today advises that Dr Christian Behrenbruch, Managing Director and Group CEO,...
Telix Radiopharmaceutical Production Facility Buildout Commences
March 21, 2022 18:41 ET
|
Telix Pharmaceuticals Limited
MELBOURNE, Australia and BRUSSELS, Belgium, March 22, 2022 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) is pleased to provide a material update on the development...
EAU Updates Guidance for PSMA-PET Imaging
March 21, 2022 01:28 ET
|
Telix Pharmaceuticals Limited
MELBOURNE, Australia and LIÈGE, Belgium, March 21, 2022 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) welcomes the updated 2022 ‘Guidelines on Prostate...